Share Price and Basic Stock Data
Last Updated: January 28, 2026, 8:25 pm
| PEG Ratio | -4.86 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
AVT Natural Products Ltd operates in the agricultural products industry, with its stock currently priced at ₹65.9 and a market capitalization of ₹1,003 Cr. The company has demonstrated a fluctuating revenue trend, with sales reported at ₹582 Cr for the fiscal year ended March 2023. This figure represents a modest increase from ₹559 Cr in the previous year. However, the trailing twelve months (TTM) sales climbed to ₹622 Cr, indicating a rebound in revenue generation. Analyzing quarterly sales, the company recorded ₹160 Cr in September 2022, which gradually declined to ₹103 Cr in June 2023 before recovering to ₹135 Cr by September 2023. This inconsistency could be attributed to seasonal factors or market demand variations. The sales trajectory implies potential growth opportunities, yet the overall revenue performance remains dependent on broader agricultural market conditions.
Profitability and Efficiency Metrics
AVT Natural Products reported a net profit of ₹61 Cr in FY 2023, reflecting a net profit margin of 13.29%. This margin is relatively healthy compared to industry averages, although it declined from 13.02% in FY 2022. The operating profit margin (OPM) stood at 21% for FY 2023, indicating effective cost management despite fluctuations in sales. The company’s return on equity (ROE) is reported at 9.89%, and return on capital employed (ROCE) is noted at 12.8%, both of which suggest reasonable efficiency in utilizing shareholder funds and capital. However, the cash conversion cycle (CCC) has lengthened to 388 days, which may indicate potential challenges in inventory turnover and receivables collection, thereby impacting liquidity. The interest coverage ratio (ICR) of 9.11x illustrates robust capacity to meet interest obligations, enhancing the overall financial stability of the firm.
Balance Sheet Strength and Financial Ratios
AVT Natural Products has a solid balance sheet, with total assets reported at ₹747 Cr as of March 2025, bolstered by reserves of ₹508 Cr and borrowings of ₹100 Cr. The company’s debt-to-equity ratio stands at 0.21, suggesting a conservative leverage position compared to industry standards. The current ratio is reported at 2.90, indicating strong short-term liquidity, while the quick ratio at 1.62 further emphasizes the company’s ability to cover immediate liabilities. The book value per share has increased to ₹33.25, reflecting enhanced shareholder value. However, the inventory turnover ratio of 2.16x suggests room for improvement in managing inventory levels, potentially impacting working capital efficiency. Overall, the financial ratios indicate a stable foundation, yet the company must address its inventory management to optimize asset utilization.
Shareholding Pattern and Investor Confidence
The shareholding pattern of AVT Natural Products reveals a dominant promoter shareholding of 75%, indicating strong control over the company. Foreign institutional investors (FIIs) hold a marginal 0.07%, while domestic institutional investors (DIIs) represent 0.24% of the equity. Public ownership stands at 24.72%, with the total number of shareholders at 50,306 as of September 2025, marking a significant increase from previous periods. This growth in shareholder base may reflect rising investor confidence in the company, though the low institutional participation could signal a lack of broader market appeal. The relatively stable promoter holding suggests commitment to long-term growth strategies, yet the low FII and DII interest may limit institutional support for capital raising initiatives or strategic expansions. This dynamic could pose challenges to liquidity and market perception in the future.
Outlook, Risks, and Final Insight
Looking ahead, AVT Natural Products faces both opportunities and challenges. The company’s strong operational metrics, such as a robust ICR and healthy margins, position it favorably within the agricultural sector. However, the extended cash conversion cycle and fluctuating sales patterns present risks that could impede growth. Additionally, the company must navigate external factors such as commodity price volatility and changing regulatory landscapes in agriculture, which could impact profitability. To enhance market positioning, AVT could focus on improving inventory turnover and expanding its product lines. The strategic initiatives, coupled with a commitment to operational efficiency, could foster sustained growth. Overall, while AVT Natural Products has a solid foundation, proactive management of operational risks and market dynamics will be essential for future success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 2,983 Cr. | 162 | 186/64.4 | 56.4 | 23.5 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 143 Cr. | 179 | 200/105 | 63.8 | 165 | 0.00 % | 7.35 % | 8.07 % | 10.0 |
| City Crops Agro Ltd | 30.7 Cr. | 18.8 | 28.2/17.0 | 15.8 | 0.00 % | 8.46 % | 8.14 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,165 Cr. | 235 | 396/228 | 12.4 | 153 | 1.06 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 409 Cr. | 12.4 | 18.5/11.5 | 14.8 | 6.86 | 0.08 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,448.80 Cr | 223.70 | 28.74 | 106.69 | 0.36% | 11.80% | 12.33% | 4.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 160 | 139 | 134 | 103 | 135 | 154 | 125 | 105 | 122 | 173 | 157 | 132 | 160 |
| Expenses | 126 | 112 | 110 | 92 | 119 | 118 | 109 | 97 | 114 | 143 | 132 | 116 | 145 |
| Operating Profit | 34 | 27 | 24 | 11 | 17 | 36 | 16 | 8 | 8 | 30 | 25 | 16 | 15 |
| OPM % | 21% | 19% | 18% | 11% | 12% | 23% | 13% | 8% | 7% | 17% | 16% | 12% | 9% |
| Other Income | 3 | -1 | -1 | 3 | 5 | -0 | 5 | 5 | 5 | 4 | 2 | 4 | 5 |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 2 | 2 |
| Depreciation | 3 | 4 | 4 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 3 | 3 |
| Profit before tax | 33 | 20 | 18 | 10 | 16 | 30 | 15 | 8 | 8 | 28 | 20 | 15 | 16 |
| Tax % | 25% | 34% | 21% | 19% | 27% | 26% | 26% | 25% | 17% | 23% | 27% | 18% | 16% |
| Net Profit | 25 | 13 | 14 | 8 | 12 | 22 | 11 | 6 | 6 | 22 | 14 | 12 | 13 |
| EPS in Rs | 1.64 | 0.88 | 0.93 | 0.55 | 0.76 | 1.47 | 0.72 | 0.39 | 0.41 | 1.42 | 0.94 | 0.80 | 0.87 |
Last Updated: January 2, 2026, 9:01 am
Below is a detailed analysis of the quarterly data for AVT Natural Products Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 160.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Jun 2025) to 160.00 Cr., marking an increase of 28.00 Cr..
- For Expenses, as of Sep 2025, the value is 145.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 116.00 Cr. (Jun 2025) to 145.00 Cr., marking an increase of 29.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Jun 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Jun 2025) to 9.00%, marking a decrease of 3.00%.
- For Other Income, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Jun 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 18.00% (Jun 2025) to 16.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Jun 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.87. The value appears strong and on an upward trend. It has increased from 0.80 (Jun 2025) to 0.87, marking an increase of 0.07.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:36 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 290 | 261 | 274 | 311 | 328 | 339 | 396 | 485 | 559 | 582 | 517 | 556 | 622 |
| Expenses | 216 | 214 | 235 | 269 | 295 | 297 | 339 | 414 | 454 | 461 | 438 | 486 | 537 |
| Operating Profit | 74 | 48 | 39 | 42 | 33 | 42 | 57 | 71 | 106 | 121 | 79 | 70 | 85 |
| OPM % | 25% | 18% | 14% | 14% | 10% | 12% | 14% | 15% | 19% | 21% | 15% | 13% | 14% |
| Other Income | 1 | 2 | 1 | 5 | 13 | 4 | 7 | 8 | 10 | 2 | 13 | 16 | 15 |
| Interest | 2 | 4 | 1 | 2 | 3 | 5 | 6 | 4 | 5 | 5 | 7 | 9 | 10 |
| Depreciation | 5 | 6 | 6 | 7 | 7 | 11 | 14 | 15 | 14 | 13 | 14 | 14 | 13 |
| Profit before tax | 67 | 41 | 33 | 38 | 36 | 30 | 45 | 61 | 97 | 105 | 71 | 63 | 78 |
| Tax % | 37% | 35% | 35% | 36% | 32% | 30% | 24% | 25% | 25% | 26% | 25% | 24% | |
| Net Profit | 42 | 26 | 22 | 24 | 24 | 21 | 34 | 45 | 73 | 77 | 53 | 48 | 61 |
| EPS in Rs | 2.76 | 1.73 | 1.42 | 1.61 | 1.59 | 1.37 | 2.23 | 2.97 | 4.78 | 5.08 | 3.50 | 3.17 | 4.03 |
| Dividend Payout % | 27% | 29% | 28% | 25% | 25% | 29% | 27% | 24% | 21% | 20% | 23% | 25% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -38.10% | -15.38% | 9.09% | 0.00% | -12.50% | 61.90% | 32.35% | 62.22% | 5.48% | -31.17% | -9.43% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.71% | 24.48% | -9.09% | -12.50% | 74.40% | -29.55% | 29.87% | -56.74% | -36.65% | 21.73% |
AVT Natural Products Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | -13% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | -12% |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 12:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:00 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 152 | 171 | 185 | 209 | 223 | 236 | 260 | 295 | 354 | 415 | 454 | 491 | 508 |
| Borrowings | 5 | 7 | 10 | 15 | 36 | 81 | 46 | 54 | 25 | 37 | 43 | 113 | 100 |
| Other Liabilities | 64 | 44 | 39 | 36 | 55 | 56 | 57 | 62 | 55 | 56 | 86 | 128 | 169 |
| Total Liabilities | 237 | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 524 | 598 | 747 | 792 |
| Fixed Assets | 51 | 53 | 58 | 57 | 56 | 98 | 99 | 89 | 82 | 78 | 82 | 72 | 63 |
| CWIP | 0 | 2 | 1 | 0 | 28 | 0 | 0 | 0 | 2 | 0 | 0 | 4 | 14 |
| Investments | 15 | 7 | 28 | 38 | 30 | 7 | 8 | 8 | 28 | 58 | 127 | 136 | 115 |
| Other Assets | 171 | 175 | 162 | 180 | 215 | 283 | 271 | 329 | 337 | 387 | 390 | 535 | 600 |
| Total Assets | 237 | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 524 | 598 | 747 | 792 |
Below is a detailed analysis of the balance sheet data for AVT Natural Products Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 508.00 Cr.. The value appears strong and on an upward trend. It has increased from 491.00 Cr. (Mar 2025) to 508.00 Cr., marking an increase of 17.00 Cr..
- For Borrowings, as of Sep 2025, the value is 100.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 113.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 169.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Mar 2025) to 169.00 Cr., marking an increase of 41.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 792.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 747.00 Cr. (Mar 2025) to 792.00 Cr., marking an increase of 45.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 9.00 Cr..
- For CWIP, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 10.00 Cr..
- For Investments, as of Sep 2025, the value is 115.00 Cr.. The value appears to be declining and may need further review. It has decreased from 136.00 Cr. (Mar 2025) to 115.00 Cr., marking a decrease of 21.00 Cr..
- For Other Assets, as of Sep 2025, the value is 600.00 Cr.. The value appears strong and on an upward trend. It has increased from 535.00 Cr. (Mar 2025) to 600.00 Cr., marking an increase of 65.00 Cr..
- For Total Assets, as of Sep 2025, the value is 792.00 Cr.. The value appears strong and on an upward trend. It has increased from 747.00 Cr. (Mar 2025) to 792.00 Cr., marking an increase of 45.00 Cr..
Notably, the Reserves (508.00 Cr.) exceed the Borrowings (100.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 69.00 | 41.00 | 29.00 | 27.00 | -3.00 | -39.00 | 11.00 | 17.00 | 81.00 | 84.00 | 36.00 | -43.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 58 | 69 | 65 | 71 | 88 | 69 | 77 | 67 | 76 | 78 | 103 |
| Inventory Days | 248 | 278 | 184 | 205 | 186 | 341 | 235 | 258 | 263 | 342 | 365 | 431 |
| Days Payable | 59 | 37 | 28 | 39 | 68 | 82 | 43 | 59 | 45 | 44 | 98 | 146 |
| Cash Conversion Cycle | 236 | 300 | 226 | 231 | 188 | 347 | 261 | 275 | 284 | 373 | 345 | 388 |
| Working Capital Days | 114 | 159 | 143 | 119 | 116 | 166 | 151 | 159 | 163 | 176 | 171 | 172 |
| ROCE % | 40% | 25% | 17% | 17% | 14% | 11% | 15% | 19% | 27% | 26% | 16% | 13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| Diluted EPS (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| Cash EPS (Rs.) | 4.08 | 4.41 | 5.96 | 5.73 | 3.97 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 33.25 | 30.83 | 28.26 | 24.21 | 20.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 33.25 | 30.83 | 28.26 | 24.21 | 20.37 |
| Revenue From Operations / Share (Rs.) | 36.51 | 33.97 | 38.23 | 36.73 | 31.86 |
| PBDIT / Share (Rs.) | 5.68 | 6.04 | 8.09 | 7.59 | 5.24 |
| PBIT / Share (Rs.) | 4.77 | 5.12 | 7.22 | 6.65 | 4.24 |
| PBT / Share (Rs.) | 4.15 | 4.67 | 6.86 | 6.35 | 3.98 |
| Net Profit / Share (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| NP After MI And SOA / Share (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| PBDIT Margin (%) | 15.55 | 17.76 | 21.17 | 20.66 | 16.43 |
| PBIT Margin (%) | 13.06 | 15.08 | 18.87 | 18.10 | 13.30 |
| PBT Margin (%) | 11.35 | 13.73 | 17.95 | 17.27 | 12.48 |
| Net Profit Margin (%) | 8.67 | 10.30 | 13.29 | 13.02 | 9.33 |
| NP After MI And SOA Margin (%) | 8.67 | 10.30 | 13.29 | 13.02 | 9.33 |
| Return on Networth / Equity (%) | 9.52 | 11.34 | 17.98 | 19.75 | 14.59 |
| Return on Capital Employeed (%) | 14.00 | 16.08 | 24.68 | 26.53 | 19.69 |
| Return On Assets (%) | 6.45 | 8.90 | 14.83 | 16.23 | 10.64 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Total Debt / Equity (X) | 0.21 | 0.07 | 0.07 | 0.05 | 0.15 |
| Asset Turnover Ratio (%) | 0.82 | 0.92 | 1.21 | 1.24 | 1.18 |
| Current Ratio (X) | 2.90 | 4.53 | 5.75 | 5.37 | 3.40 |
| Quick Ratio (X) | 1.62 | 2.57 | 2.98 | 2.64 | 1.72 |
| Inventory Turnover Ratio (X) | 2.16 | 0.94 | 1.45 | 1.49 | 1.84 |
| Dividend Payout Ratio (NP) (%) | 25.26 | 25.71 | 19.67 | 16.72 | 21.85 |
| Dividend Payout Ratio (CP) (%) | 19.62 | 20.40 | 16.77 | 13.96 | 16.37 |
| Earning Retention Ratio (%) | 74.74 | 74.29 | 80.33 | 83.28 | 78.15 |
| Cash Earning Retention Ratio (%) | 80.38 | 79.60 | 83.23 | 86.04 | 83.63 |
| Interest Coverage Ratio (X) | 9.11 | 13.20 | 23.02 | 25.04 | 19.89 |
| Interest Coverage Ratio (Post Tax) (X) | 6.08 | 8.65 | 15.46 | 16.78 | 12.30 |
| Enterprise Value (Cr.) | 894.31 | 1285.96 | 1216.71 | 1993.77 | 716.44 |
| EV / Net Operating Revenue (X) | 1.61 | 2.49 | 2.09 | 3.56 | 1.48 |
| EV / EBITDA (X) | 10.34 | 13.99 | 9.87 | 17.24 | 8.99 |
| MarketCap / Net Operating Revenue (X) | 1.48 | 2.47 | 2.07 | 3.55 | 1.41 |
| Retention Ratios (%) | 74.73 | 74.28 | 80.32 | 83.27 | 78.14 |
| Price / BV (X) | 1.62 | 2.72 | 2.80 | 5.39 | 2.21 |
| Price / Net Operating Revenue (X) | 1.48 | 2.47 | 2.07 | 3.55 | 1.41 |
| EarningsYield | 0.05 | 0.04 | 0.06 | 0.03 | 0.06 |
After reviewing the key financial ratios for AVT Natural Products Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.17. This value is below the healthy minimum of 5. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.17. This value is below the healthy minimum of 5. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 4.08. This value is within the healthy range. It has decreased from 4.41 (Mar 24) to 4.08, marking a decrease of 0.33.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.25. It has increased from 30.83 (Mar 24) to 33.25, marking an increase of 2.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.25. It has increased from 30.83 (Mar 24) to 33.25, marking an increase of 2.42.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 36.51. It has increased from 33.97 (Mar 24) to 36.51, marking an increase of 2.54.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.68. This value is within the healthy range. It has decreased from 6.04 (Mar 24) to 5.68, marking a decrease of 0.36.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.77. This value is within the healthy range. It has decreased from 5.12 (Mar 24) to 4.77, marking a decrease of 0.35.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.15. This value is within the healthy range. It has decreased from 4.67 (Mar 24) to 4.15, marking a decrease of 0.52.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.17. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.17. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For PBDIT Margin (%), as of Mar 25, the value is 15.55. This value is within the healthy range. It has decreased from 17.76 (Mar 24) to 15.55, marking a decrease of 2.21.
- For PBIT Margin (%), as of Mar 25, the value is 13.06. This value is within the healthy range. It has decreased from 15.08 (Mar 24) to 13.06, marking a decrease of 2.02.
- For PBT Margin (%), as of Mar 25, the value is 11.35. This value is within the healthy range. It has decreased from 13.73 (Mar 24) to 11.35, marking a decrease of 2.38.
- For Net Profit Margin (%), as of Mar 25, the value is 8.67. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 8.67, marking a decrease of 1.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.67. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 8.67, marking a decrease of 1.63.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.52. This value is below the healthy minimum of 15. It has decreased from 11.34 (Mar 24) to 9.52, marking a decrease of 1.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.00. This value is within the healthy range. It has decreased from 16.08 (Mar 24) to 14.00, marking a decrease of 2.08.
- For Return On Assets (%), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 8.90 (Mar 24) to 6.45, marking a decrease of 2.45.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.21, marking an increase of 0.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.82. It has decreased from 0.92 (Mar 24) to 0.82, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 2.90. This value is within the healthy range. It has decreased from 4.53 (Mar 24) to 2.90, marking a decrease of 1.63.
- For Quick Ratio (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has decreased from 2.57 (Mar 24) to 1.62, marking a decrease of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.16. This value is below the healthy minimum of 4. It has increased from 0.94 (Mar 24) to 2.16, marking an increase of 1.22.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 25.26. This value is within the healthy range. It has decreased from 25.71 (Mar 24) to 25.26, marking a decrease of 0.45.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.62. This value is below the healthy minimum of 20. It has decreased from 20.40 (Mar 24) to 19.62, marking a decrease of 0.78.
- For Earning Retention Ratio (%), as of Mar 25, the value is 74.74. This value exceeds the healthy maximum of 70. It has increased from 74.29 (Mar 24) to 74.74, marking an increase of 0.45.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.38. This value exceeds the healthy maximum of 70. It has increased from 79.60 (Mar 24) to 80.38, marking an increase of 0.78.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.11. This value is within the healthy range. It has decreased from 13.20 (Mar 24) to 9.11, marking a decrease of 4.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.08. This value is within the healthy range. It has decreased from 8.65 (Mar 24) to 6.08, marking a decrease of 2.57.
- For Enterprise Value (Cr.), as of Mar 25, the value is 894.31. It has decreased from 1,285.96 (Mar 24) to 894.31, marking a decrease of 391.65.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.61. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 1.61, marking a decrease of 0.88.
- For EV / EBITDA (X), as of Mar 25, the value is 10.34. This value is within the healthy range. It has decreased from 13.99 (Mar 24) to 10.34, marking a decrease of 3.65.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 1.48, marking a decrease of 0.99.
- For Retention Ratios (%), as of Mar 25, the value is 74.73. This value exceeds the healthy maximum of 70. It has increased from 74.28 (Mar 24) to 74.73, marking an increase of 0.45.
- For Price / BV (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has decreased from 2.72 (Mar 24) to 1.62, marking a decrease of 1.10.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 1.48, marking a decrease of 0.99.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AVT Natural Products Ltd:
- Net Profit Margin: 8.67%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14% (Industry Average ROCE: 11.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.52% (Industry Average ROE: 12.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.3 (Industry average Stock P/E: 28.74)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.21
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.67%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | 60, Rukmani Lakshmipathy Salai, Chennai (Madras) Tamil Nadu 600008 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ajit Thomas | Chairman |
| Mr. A D Bopana | Director |
| Mrs. Shanthi Thomas | Director |
| Mrs. Kavitha Vijay | Director |
| Mr. M M Venkatachalam | Director |
| Mr. Ranganath N Krishna | Director |
| Mr. Rahul Thomas | Director |
FAQ
What is the intrinsic value of AVT Natural Products Ltd?
AVT Natural Products Ltd's intrinsic value (as of 28 January 2026) is ₹43.34 which is 33.93% lower the current market price of ₹65.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,001 Cr. market cap, FY2025-2026 high/low of ₹83.9/51.0, reserves of ₹508 Cr, and liabilities of ₹792 Cr.
What is the Market Cap of AVT Natural Products Ltd?
The Market Cap of AVT Natural Products Ltd is 1,001 Cr..
What is the current Stock Price of AVT Natural Products Ltd as on 28 January 2026?
The current stock price of AVT Natural Products Ltd as on 28 January 2026 is ₹65.6.
What is the High / Low of AVT Natural Products Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of AVT Natural Products Ltd stocks is ₹83.9/51.0.
What is the Stock P/E of AVT Natural Products Ltd?
The Stock P/E of AVT Natural Products Ltd is 16.3.
What is the Book Value of AVT Natural Products Ltd?
The Book Value of AVT Natural Products Ltd is 34.4.
What is the Dividend Yield of AVT Natural Products Ltd?
The Dividend Yield of AVT Natural Products Ltd is 1.07 %.
What is the ROCE of AVT Natural Products Ltd?
The ROCE of AVT Natural Products Ltd is 12.8 %.
What is the ROE of AVT Natural Products Ltd?
The ROE of AVT Natural Products Ltd is 9.89 %.
What is the Face Value of AVT Natural Products Ltd?
The Face Value of AVT Natural Products Ltd is 1.00.